Insider · CIK 0001504537
Mathieu B. Streiff
Files at AHR (American Healthcare REIT, Inc.). First filing Feb 13, 2024, latest Feb 13, 2024.
In brief
Mathieu B. Streiff files SEC Form 4 as director at AHR (American Healthcare REIT, Inc.). Since Feb 13, 2024, Mathieu B. Streiff has reported 1 open-market buy worth $1000k and 0 open-market sells worth $0, the latest filed on Feb 13, 2024.
A track record needs three past buys with six months of prices behind them; Mathieu B. Streiff has 0, so none is measured yet.
The newest scored trade: bought $1000k of AHR on Feb 9, 2024, filed Feb 13, 2024, scored 68 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AHR: American Healthcare REIT, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 68Notable | American Healthcare REIT, Inc. | $1000k 83,333 shares | +1125% | +0% from low-1% from high |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | AHR American Healthcare REIT, Inc. | AGrant or award Common Stock | +2,594 | $0.00 | $0 | 34,971 | Jun 26, 2026 |
| Jun 25, 2025 | AHR American Healthcare REIT, Inc. | AGrant or award Common Stock | +3,042 | $0.00 | $0 | 32,377 | Jun 27, 2025 |
| Nov 7, 2024 | AHR American Healthcare REIT, Inc. | AGrant or award Common Stock | +3,610 | $0.00 | $0 | 29,335 | Nov 12, 2024 |
| Aug 5, 2024 | AHR American Healthcare REIT, Inc. | JOther Class T Common Stock | -18,318 | - | - | 0 | Aug 7, 2024 |
| Aug 5, 2024 | AHR American Healthcare REIT, Inc. | JOther Common Stock | +18,318 | - | - | 25,725 | Aug 7, 2024 |
| Aug 5, 2024 | AHR American Healthcare REIT, Inc. | JOther Class I Common Stockindirect: By The Streiff Family Trust UA DTD 03/26/2013 | -62,124 | - | - | 0 | Aug 7, 2024 |
| Aug 5, 2024 | AHR American Healthcare REIT, Inc. | JOther Common Stockindirect: By The Streiff Family Trust UA DTD 03/26/2013 | +62,124 | - | - | 145,457 | Aug 7, 2024 |
| Aug 5, 2024 | AHR American Healthcare REIT, Inc. | JOther Class T Common Stockindirect: By The Streiff Family Trust UA DTD 03/26/2013 | -11,946 | - | - | 0 | Aug 7, 2024 |
| Aug 5, 2024 | AHR American Healthcare REIT, Inc. | JOther Common Stockindirect: By The Streiff Family Trust UA DTD 03/26/2013 | +11,945 | - | - | 157,402 | Aug 7, 2024 |
| Jun 26, 2024 | AHR American Healthcare REIT, Inc. | GGift Common Stock | -83,333 | - | - | 7,407 | Jun 27, 2024 |
| Jun 26, 2024 | AHR American Healthcare REIT, Inc. | GGift Common Stockindirect: By The Streiff Family Trust UA DTD 03/26/2013 | +83,333 | - | - | 83,333 | Jun 27, 2024 |
| Feb 9, 2024 | AHR American Healthcare REIT, Inc. | AGrant or award Common Stock | +7,407 | $0.00 | $0 | 7,407 | Feb 13, 2024 |
| Feb 9, 2024 | AHR American Healthcare REIT, Inc. | POpen-market purchase Common Stock | +83,333 | $12.00 | $1000k | 90,740 | Feb 13, 2024 |
Questions about Mathieu B. Streiff
Answered from the filings on this page, as of the latest one.
Is Mathieu B. Streiff buying or selling?
Not in the last 12 months. Mathieu B. Streiff's latest open-market trade on SEC Form 4 was bought $1000k of AHR on Feb 9, 2024.
How did Mathieu B. Streiff's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mathieu B. Streiff has 0.
Where does Mathieu B. Streiff file Form 4?
Mathieu B. Streiff has filed Form 4 at AHR (American Healthcare REIT, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.